F-18 FDG PET/CT Findings of a Case of Sacral Nerve Root Neurolymphomatosis That Occurred During Chemotherapy

Baehring, 2003, Neurolymphomatosis., Neuro Oncol, 5, 104, 10.1215/15228517-5-2-104

Gan, 2010, Neurolymphomatosis: diagnosis, management, and outcomes in patients treated with rituximab., Neuro Oncol, 12, 212, 10.1093/neuonc/nop021

Dong, 2008, Sacral nerve root neurolymphomatosis diagnosed on FDG-PET/CT and magnetic resonance imaging., Clin Nucl Med, 33, 30, 10.1097/RLU.0b013e31815c5020

Trojan, 2002, Fusion PET-CT imaging of neurolymphomatosis., Ann Oncol, 13, 802, 10.1093/annonc/mdf057

Kanter, 2005, PET-CT imaging of combined brachial and lumbosacral neurolymphomatosis., Eur J Haematol, 74, 66, 10.1111/j.1600-0609.2004.00369.x

Bokstein, 2005, Assessment of neurolymphomatosis by brachial plexus biopsy and PET/CT. Report of a case., J Neurooncol, 72, 163, 10.1007/s11060-004-3389-0

Rosso, 2006, Diagnosis of neurolymphomatosis with FDG-PET., Neurology, 67, 722, 10.1212/01.wnl.0000230155.67464.37

von Falck, 2009, F-18 2-fluoro-2-deoxy-glucose positron emission tomography/computed tomography for the detection of radicular and peripheral neurolymphomatosis: correlation with magnetic resonance imaging and ultrasound., Clin Nucl Med, 34, 493, 10.1097/RLU.0b013e3181abb6ba

Hoshikawa, 2007, A case of neurolymphomatosis diagnosed with FDG-PET [in Japanese]., Rinsho Shinkeigaku, 47, 437

Strobel, 2007, Sciatic nerve neurolymphomatosis—extent and therapy response assessment with PET/CT., Clin Nucl Med, 32, 646, 10.1097/RLU.0b013e3180a1ac74

Lin, 2008, Neurolymphomatosis—diagnosis and assessment of treatment response by FDG PET-CT., Hematol Oncol, 26, 43, 10.1002/hon.837

Czepczyński, 2008, Neurolymphomatosis detected by (18)F-FDG PET/CT scan—a case report., Nucl Med Rev Cent East Eur, 11, 73

Shima, 2008, A linear lesion along the brachial plexus on FDG-PET in neurolymphomatosis., Intern Med, 47, 1159, 10.2169/internalmedicine.47.1104